CTNM as of Nov 3 · 00:46 ET
CTNMNasdaqPharmaceutical Preparations

Contineum Therapeutics, Inc. · Brief

Next report

Today

Nov 3 · after closeest.Q3 FY26

Expected move

Inputs

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26—▼−1.65%—
quarterimplied−5%0+5%realized×
Q2 FY26—▼−1.65%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull1

+7.40%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

21managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
3 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

CTNM report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 30impliedImplied move: ±32.6% into Nov 3 earnings (Oct 30 close).Source
Oct 15impliedImplied move: ±37.1% into Oct 29 earnings (Oct 15 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.